Another study, using a selective class I and II HDAC inhibitor (ITF2357) demonstrated reduced disease in NZB/W F1 mice, suggesting that class I and II HDAC are involved in lupus pathogenesis [117]. This evidence concerns the gene HDAC9 and systemic lupus erythematosus.